doi: 10.1016/j.aquaculture.2019.734288 230 PereiraG
Hosoya-Ohmura, S
Raw264.7 were cultured in six-well plates at a density of 3 10 5 cells/well
doi: 10.3389/fphar.2025.1606804 Received 06 April 2025 Accepted 27 June 2025 Published 15 July 2025 Volume 16 - 2025 Edited by Venkatesh Pooladanda, Harvard Medical School, United States Reviewed by Lopmudra Sarode, Nagpur Veterinary College, India Sreelakshmi Badavenkatappa Gari, Jawaharlal Nehru Technological University, India Updates Copyright 2025 Shi, Lu, Wei, Ma, Li, Li, Wang, Wang, Xu and Cui
[6-Bromo-7-[[(2,4,6-Trimethylphenyl)amino]carbonyl]-2-benzothiazolyl]carbamic acid, 1,1-dimethylethyl ester Example 12 Preparation of [7-[[(2,4,6-Trimethylphenyl)amino]carbonyl]-2-benzothiazolyl]carbamic acid, 1,1-dimethylethyl ester Example 13 Preparation of [6-Bromo-5-[[(2,4,6-Trimethylphenyl)amino]carbonyl]-2-benzothiazolyl]carbamic acid, 1.1-dimethylethyl ester Example 14 Preparation of [5-[[(2,4,6-Trimethylphenyl)amino]carbonyl]-2-benzothiazolyl]carbamic acid, 1,1-dimethylethyl ester Example 15 Preparation of 2-[[[Phenylamino]carbonyl]amino]-N-(2,4,6-trimethylphenyl)-6-benzothiazolecarboxamide Example 16 Preparation of 2-[[[(Phenylmethyl)amino]carbonyl]amino]-N-(2,4,6-trimethylphenyl)-6-benzothiazolecarboxamide Example 17 Preparation of 2-[[[Ethylamino]carbonyl]amino]-N-(2,4,6-trimethylphenyl)-6-benzothiazolecarboxamide Example 18 Preparation of 2-[[(Butylamino)carbonyl]amino]-N-(2,4,6-trimethylphenyl)-6-benzothiazolecarboxamide Examples 19 to 58 General Procedure Examples 59 to 95 General Procedure Examples 96 to 140 General Procedure Examples 141 to 163 General Procedure A
On contrary, growing evidence has emerged that GSK-3 is anti-apoptotic
